The ReSViNET Foundation and ReSViNET’s Patient Network were partners in IMI’s PROMISE study. The aim of PROMISE was to significantly advance our understanding of RSV to aid in the design of public health strategies as well as the development and use of vaccines and therapeutics in both children and older people. It built on the work of IMI’s RESCEU project, which delivered significant insights and resources on RSV.
